Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
C-CAR011
BIOLOGICAL
3 trials
Sponsors
Shanghai AbelZeta Ltd.
, Peking University People's Hospital
Conditions
Acute Lymphoblastic Leukemia(ALL)
Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
Refractory or Relapsed Non-Hodgkin Lymphoma
Phase 1
Study of Safety and Efficacy of C-CAR011 in B-NHL Patients
NCT03154775
Shanghai AbelZeta Ltd.
Refractory or Relapsed Non-Hodgkin Lymphoma
Start: 2017-05-03
End: 2018-12-31
Target: 15
Updated: 2017-05-16
A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL
NCT03299738
Shanghai AbelZeta Ltd.
Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
Start: 2017-12-31
End: 2019-08-31
Target: 10
Updated: 2017-12-19
Unknown Phase
C-CAR011 Treatment in Subjects With ALL After HSCT
NCT03327285
Peking University People's Hospital
Acute Lymphoblastic Leukemia(ALL)
Start: 2018-03-01
End: 2021-04-30
Target: 40
Updated: 2020-10-01
Related Papers
Development and Validation of a Clinical Prediction Model for the Efficacy of CD19 CAR T-Cell Therapy in DLBCL
Blood
2023-11-02